Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial

被引：0
|
作者：
Zahra Darabi
Mina Darand
Zahra Yari
Mehdi Hedayati
Amirhosein Faghihi
Shahram Agah
Azita Hekmatdoost
机构：
[1] Shahid Beheshti University of Medical Sciences,Department of Clinical Nutrition and Dietetics, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute
[2] Shahid Beheshti University of Medical Sciences,Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences
[3] Iran University of Medical Sciences,Colorectal Research Center
来源：
BMC Research Notes | / 12卷
关键词：
Citrulline; NAFLD; Fatty liver; Inflammation; NASH;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial
    Ebrahimi-Mameghani, Mehrangiz
    Sadeghi, Zahra
    Farhangi, Mandieh Abbasalizad
    Vaghef-Mehrabany, Elnaz
    Aliashrafi, Soodabeh
    CLINICAL NUTRITION, 2017, 36 (04) : 1001 - 1006
  • [22] Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Haleh Chehrehgosha
    Masoud Reza Sohrabi
    Faramarz Ismail-Beigi
    Mojtaba Malek
    Mohammad Reza Babaei
    Farhad Zamani
    Hossein Ajdarkosh
    Mahmood Khoonsari
    Afshin Eshghi Fallah
    Mohammad E. Khamseh
    Diabetes Therapy, 2021, 12 : 843 - 861
  • [23] Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Chehrehgosha, Haleh
    Sohrabi, Masoud Reza
    Ismail-Beigi, Faramarz
    Malek, Mojtaba
    Babaei, Mohammad Reza
    Zamani, Farhad
    Ajdarkosh, Hossein
    Khoonsari, Mahmood
    Fallah, Afshin Eshghi
    Khamseh, Mohammad E.
    DIABETES THERAPY, 2021, 12 (03) : 843 - 861
  • [24] Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
    Hoda Taheri
    Mojtaba Malek
    Faramarz Ismail-Beigi
    Farhad Zamani
    Masoudreza Sohrabi
    Mohammad Reza babaei
    Mohammad E. Khamseh
    Advances in Therapy, 2020, 37 : 4697 - 4708
  • [25] Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
    Taheri, Hoda
    Malek, Mojtaba
    Ismail-Beigi, Faramarz
    Zamani, Farhad
    Sohrabi, Masoudreza
    Reza Babaei, Mohammad
    Khamseh, Mohammad E.
    ADVANCES IN THERAPY, 2020, 37 (11) : 4697 - 4708
  • [26] Impact of Long-Term Supplementation with Fish Oil in Individuals with Non-Alcoholic Fatty Liver Disease: A Double Blind Randomized Placebo Controlled Clinical Trial
    Cansancao, Katia
    Citelli, Marta
    Carvalho Leite, Nathalie
    Lopez de las Hazas, Maria-Carmen
    Davalos, Alberto
    Tavares do Carmo, Maria das Gracas
    Peres, Wilza Arantes Ferreira
    NUTRIENTS, 2020, 12 (11) : 1 - 12
  • [27] The effects of zinc supplementation on metabolic profile and oxidative stress in overweight/obese patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial
    Fathi, Mojdeh
    Alavinejad, Pezhman
    Haidari, Zahra
    Amani, Reza
    JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2020, 62
  • [28] Effect of Phytosomal Curcumin on Circulating Levels of Adiponectin and Leptin in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Mirhafez, Seyed Reza
    Farimani, Azam Rezaei
    Dehhabe, Maryam
    Bidkhori, Mohammad
    Hariri, Mitra
    Ghouchani, Bibi Fatemeh Nobakht Motlagh
    Abdollahi, Fatemeh
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2019, 28 (02) : 183 - 189
  • [29] Randomised Double-Blind Placebo-Controlled Trial of Inulin with Metronidazole in Non-Alcoholic Fatty Liver Disease (NAFLD)
    Chong, Clara Yieh Lin
    Orr, David
    Plank, Lindsay D.
    Vatanen, Tommi
    O'Sullivan, Justin M.
    Murphy, Rinki
    NUTRIENTS, 2020, 12 (04)
  • [30] Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
    Saadati, Saeede
    Sadeghi, Amir
    Mansour, Asieh
    Yari, Zahra
    Poustchi, Hossein
    Hedayati, Mehdi
    Hatami, Behzad
    Hekmatdoost, Azita
    BMC GASTROENTEROLOGY, 2019, 19 (1)
12345